Salarius Pharmaceuticals Gets FDA Clearance for Lymphoma Drug Application

July 11, 2023 13:01 UTC

Trending Today

Belarus Frees Nobel Prize Laureate, Other Prominent Political Prisoners As U.S. Lifts Sanctions

Affordable Care Act Enrollees Say Expiring Subsidies Will Hit Them Hard

Trump Gives Slippery Answer When Asked If Venezuela Conflict Is About Oil: 'Well...'

My Little Pony Helped Me Cope With My Dad Dying Of Cancer

Salarius Pharmaceuticals Gets FDA Clearance for Lymphoma Drug Application

By Dean SealSalarius Pharmaceuticals said regulators have cleared an investigational drug application to start a clinical trial for its lymphoma treatment SP-3164. The clinical-stage biopharmaceutical company said the go-ahead from the U.S. Food and Drug Administration allows it to commence a Phase 1 clinical trial of SP-3164 in patients...

Source: Wall Street Journal July 11, 2023 13:01 UTC

Meta says China experimenting with Facebook influence tactics

McDonald’s is getting rid of these sweet menu items

Jayshree Ullal makes it to Forbes' ‘100 Richest Self-Made Women’ List: All you need to know